118 related articles for article (PubMed ID: 38514264)
1. [Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma].
Yang JL; Fang RF; Xie Q; Tai BJ; Yao DF; Yao M
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):148-154. PubMed ID: 38514264
[No Abstract] [Full Text] [Related]
2. [Expression of tuftelin protein and its clinical value in HBV-related liver cancer tissues].
Wu MN; Yang JL; Shen SJ; Wang L; Zheng WJ; Wu W; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):338-343. PubMed ID: 33979960
[No Abstract] [Full Text] [Related]
3. Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth.
Wu MN; Zheng WJ; Ye WX; Wang L; Chen Y; Yang J; Yao DF; Yao M
World J Gastroenterol; 2021 Jun; 27(23):3327-3341. PubMed ID: 34163115
[TBL] [Abstract][Full Text] [Related]
4. [Effect of TUTF1 expression on the proliferation, apoptosis and prognosis of hepatocellular carcinoma cells].
Li ZJ; Li JS; Li DY; Pu T
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):879-884. PubMed ID: 31941243
[No Abstract] [Full Text] [Related]
5. [Value of abnormal expression of Krüppel-like zinc-finger protein transcription factor 5 in the diagnosis and prognosis of liver cancer].
Sai WL; Wang L; Sun JY; Yang JL; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):781-787. PubMed ID: 34517461
[No Abstract] [Full Text] [Related]
6. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
7. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis.
Xiao Z; Liu Y; Zhao J; Li L; Hu L; Lu Q; Zeng Z; Liu X; Huang D; Yang W; Xu Q
Int J Biol Sci; 2020; 16(13):2296-2305. PubMed ID: 32760198
[TBL] [Abstract][Full Text] [Related]
9. Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation.
Zhu L; Zhou KX; Ma MZ; Yao LL; Zhang YL; Li H; Du C; Yang XM
J Immunol Res; 2022; 2022():1590717. PubMed ID: 35769513
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of PUMA expression in patients with HBV-related hepatocellular carcinoma.
Peng SL; Yao DB; Zhao Y; Xu F; Jia CJ; Xu YQ; Dai CL
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):38-44. PubMed ID: 25635973
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca
Dou C; Zhou Z; Xu Q; Liu Z; Zeng Y; Wang Y; Li Q; Wang L; Yang W; Liu Q; Tu K
Oncogene; 2019 Feb; 38(8):1239-1255. PubMed ID: 30250300
[TBL] [Abstract][Full Text] [Related]
12. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
13. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor Krüppel-like factor 5 promotes cell growth and metastasis via activating PI3K/AKT/Snail signaling in hepatocellular carcinoma.
An T; Dong T; Zhou H; Chen Y; Zhang J; Zhang Y; Li Z; Yang X
Biochem Biophys Res Commun; 2019 Jan; 508(1):159-168. PubMed ID: 30473218
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
16. Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro.
Guo L; Gao S; Sun W; Wang Y; Zhao J
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101813. PubMed ID: 34583064
[TBL] [Abstract][Full Text] [Related]
17. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
[TBL] [Abstract][Full Text] [Related]
18. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
19. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
[TBL] [Abstract][Full Text] [Related]
20. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
Oncol Rep; 2016 Apr; 35(4):2382-90. PubMed ID: 26882953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]